top of page
Home
About
Selected work
Contact
Selected work
A selection of my features, investigations and news reporting.
Previous
01
Clozapine: is it time to relax blood
monitoring rules?
A feature exploring whether longstanding blood monitoring requirements for clozapine remain justified in light of emerging international research. One of The Pharmaceutical Journal's most-read articles of 2025.
02
Is a lack of protected learning time holding back hospital pharmacists’ career development?
An exclusive investigation analysing Freedom of Information data from NHS trusts and health boards across Great Britain to examine access to protected learning time for hospital pharmacists.
03
Why are increasing numbers of students dropping out of pharmacy education?
An investigation of the factors behind rising attrition in pharmacy education. This article was recognised as part of my winning submission for the Avicenna Media Awards Newcomer of the Year 2024.
04
Is a cure for epidermolysis bullosa
on the horizon?
A feature exploring advances in research into epidermolysis bullosa, translating complex scientific developments into an accessible story while highlighting the experiences of patients and the clinicians working towards new treatments.
05
Number of overseas pharmacists applying to work in UK falls by two-thirds in one year
An exclusive news story on a decline in the number of overseas pharmacists applying to work in the UK. Recognised as part of my Avicenna Media Awards Newcomer of the Year 2024 Award.
06
Delivering advanced services under the new pharmacy contract
A news analysis on the opportunities and challenges presented by the new community pharmacy contract, combining policy reporting, exclusive data analysis and interviews to explain how contractual changes could affect pharmacy practice and patient care.
Next
01 / 06
Close
Previous
Next
Clozapine: is it time to relax blood
monitoring rules?
A feature exploring whether longstanding blood monitoring requirements for clozapine remain justified in light of emerging international research. One of The Pharmaceutical Journal's most-read articles of 2025.
Go to link
01
Clozapine: is it time to relax blood
monitoring rules?
A feature exploring whether longstanding blood monitoring requirements for clozapine remain justified in light of emerging international research. One of The Pharmaceutical Journal's most-read articles of 2025.
02
Is a lack of protected learning time holding back hospital pharmacists’ career development?
An exclusive investigation analysing Freedom of Information data from NHS trusts and health boards across Great Britain to examine access to protected learning time for hospital pharmacists.
03
Why are increasing numbers of students dropping out of pharmacy education?
An investigation of the factors behind rising attrition in pharmacy education. This article was recognised as part of my winning submission for the Avicenna Media Awards Newcomer of the Year 2024.
04
Is a cure for epidermolysis bullosa
on the horizon?
A feature exploring advances in research into epidermolysis bullosa, translating complex scientific developments into an accessible story while highlighting the experiences of patients and the clinicians working towards new treatments.
05
Number of overseas pharmacists applying to work in UK falls by two-thirds in one year
An exclusive news story on a decline in the number of overseas pharmacists applying to work in the UK. Recognised as part of my Avicenna Media Awards Newcomer of the Year 2024 Award.
06
Delivering advanced services under the new pharmacy contract
A news analysis on the opportunities and challenges presented by the new community pharmacy contract, combining policy reporting, exclusive data analysis and interviews to explain how contractual changes could affect pharmacy practice and patient care.
bottom of page
